Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 2, 2013, Pages 183-190

  Muzzi, Mirko ^a   Blasi, Francesco ^a   Masi, Alessio ^a   Coppi, Elisabetta ^a   Traini, Chiara ^a   Felici, Roberta ^a   Pittelli, Maria ^a   Cavone, Leonardo ^a   Pugliese, Anna Maria ^a   Moroni, Flavio ^a   Chiarugi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

A1R; AMP; fever; hypothalamus; hypothermia

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5' NUCLEOTIDASE; ADENOSINE A1 RECEPTOR; ADENOSINE PHOSPHATE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTHERMIA; HYPOTHALAMUS; INDUCED HYPOTHERMIA; MALE; MOUSE; NERVE CELL; NONHUMAN; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN DEGRADATION; SENSITIVITY ANALYSIS; TEMPERATURE; THERMOREGULATION;

5'-NUCLEOTIDASE; ADENOSINE MONOPHOSPHATE; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BODY TEMPERATURE REGULATION; DINOPROSTONE; FEVER; HUMANS; HYPOTHERMIA, INDUCED; MALE; MICE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE TISSUE PROTEINS; NEURONS; OXYTOCICS; PREOPTIC AREA; PRESCRIPTION DRUG MISUSE; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1;

EID: 84873406263     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.157     Document Type: Article

References (31)

1. Yenari MA, Han HS. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci 2012; 13: 267-278.
2. Yenari MA, Hemmen TM. Therapeutic hypothermia for brain ischemia: where have we come and where do we go? Stroke 2010; 41: S72-S74.
3. Shah PS. Hypothermia: a systematic review and meta-analysis of clinical trials. Semin Fetal Neonatal Med 2010; 15: 238-246.
4. Diller KR, Zhu L. Hypothermia therapy for brain injury. Annu Rev Biomed Eng 2009; 11: 135-162.
5. Testori C, Sterz F, Behringer W, Spiel A, Firbas C, Jilma B. Surface cooling for induction of mild hypothermia in conscious healthy volunteers-a feasibility trial. Crit Care 2011; 15: R248.
6. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002; 346: 1978-1988.
7. van der Worp HB, Macleod MR, Kollmar R. Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab 2010; 30: 1079-1093.
8. Lee CC. Is human hibernation possible? Annu Rev Med 2008; 59: 177-186.
9. Zhang J, Kaasik K, Blackburn MR, Lee CC. Constant darkness is a circadian metabolic signal in mammals. Nature 2006; 439: 340-343.
10. Zhang F, Wang S, Luo Y, Ji X, Nemoto EM, Chen J. When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5-monopho-sphate on cerebral ischemia in rats. J Cereb Blood Flow Metab 2009; 29: 1022-1034.
11. Muzzi M, Felici R, Cavone L, Gerace E, Minassi A, Appendino G et al. Ischemic neuroprotection by TRPV1 receptor-induced hypothermia. J Cereb Blood Flow Metab 2012; 32: 978-982.
12. Faraco G, Pittelli M, Cavone L, Fossati S, Porcu M, Mascagni P et al. Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiol Dis 2009; 36: 269-279.
13. Latini S, Bordoni F, Pedata F, Corradetti R. Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 1999; 127: 729-739.
14. Coppi E, Pugliese AM, Stephan H, Muller CE, Pedata F. Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices. Purinergic Signal 2007; 3: 203-219.
15. Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5-nucleotidase (CD73). Purinergic Signal 2006; 2: 351-360.
16. Nakata H, Yoshioka K, Kamiya T, Tsuga H, Oyanagi K. Functions of heteromeric association between adenosine and P2Y receptors. J Mol Neurosci 2005; 26: 233-238.
17. Fishman P, Bar-Yehuda S, Liang BT, Jacobson KA. Pharmacological and therapeutic effects of A(3) adenosine receptor agonists. Drug Discov Today 2012; 17: 359-366.
18. Huber-Ruano I, Pastor-Anglada M. Transport of nucleoside analogs across the plasma membrane: a clue to understanding drug-induced cytotoxicity. Curr Drug Metab 2009; 10: 347-358.
19. Lovatt D, Xu Q, Liu W, Takano T, Smith NA, Schnermann J et al. Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci USA 2012; 109: 6265-6270.
20. Wetherington JP, Lambert NA. Differential desensitization of responses mediated by presynaptic and postsynaptic A1 adenosine receptors. J Neurosci 2002; 22: 1248-1255.
21. Podgorska M, Kocbuch K, Pawelczyk T. Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta Biochim Pol 2005; 52: 749-758.
22. Boulant JA. Neuronal basis of Hammel's model for set-point thermoregulation. J Appl Physiol 2006; 100: 1347-1354.
23. Morrison SF, Nakamura K. Central neural pathways for thermoregulation. Front Biosci 2011; 16: 74-104.
24. Parrott AC. MDMA and temperature: A review of the thermal effects of 'Ecstasy' in humans. Drug Alcohol Depend 2012; 121: 1-9.
25. Ikeda M, Sagara M, Sekino Y, Shirao T, Honda K, Yoshioka T et al. The sulphydryl reagent, N-ethylmaleimide, disrupts sleep and blocks A1 adenosine receptor-mediated inhibition of intracellular calcium signaling in the in vitro ventromedial preoptic nucleus. Neuroscience 2001; 106: 733-743.
26. Thakkar MM, Winston S, McCarley RW. Orexin neurons of the hypothalamus express adenosine A1 receptors. Brain Res 2002; 944: 190-194.
27. Zylka MJ. Pain-relieving prospects for adenosine receptors and ectonucleotidases. Trends Mol Med 2011; 17: 188-196.
28. Rittiner JE, Korboukh I, Hull-Ryde EA, Jin J, Janzen WP, Frye SV et al. AMP is an adenosine A1 receptor agonist. J Biol Chem 2012; 287: 5301-5309.
29. Zhang D, Xiong W, Albensi BC, Parkinson FE. Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions. J Neurochem 2011; 118: 4-11.
30. Langer D, Hammer K, Koszalka P, Schrader J, Robson S, Zimmermann H. Distribution of ectonucleotidases in the rodent brain revisited. Cell Tissue Res 2008; 334: 199-217.
31. Camici M, Micheli V, Ipata PL, Tozzi MG. Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochem Int 2010; 56: 367-378.